Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

829 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tumor Growth Suppression With Novel Intra-arterial Chemotherapy Using Epirubicin-entrapped Water-in-oil-in-water Emulsion In Vivo.
Yanagie H, Fujino T, Yanagawa M, Terao T, Imagawa T, Fujihara M, Morishita Y, Mizumachi R, Murata Y, Dewi N, Ono Y, Ikushima I, Seguchi K, Nagata M, Nonaka Y, Furuya Y, Hisa T, Nagasaki T, Arimori K, Nakashima T, Sugihara T, Kakimi K, Ono M, Nakajima J, Eriguchi M, Higashi S, Takahashi H. Yanagie H, et al. Among authors: sugihara t. In Vivo. 2021 Jan-Feb;35(1):239-248. doi: 10.21873/invivo.12252. In Vivo. 2021. PMID: 33402470 Free PMC article.
Suppression of Tumor Growth in a Rabbit Hepatic Cancer Model by Boron Neutron Capture Therapy With Liposomal Boron Delivery Systems.
Yanagie H, Yanagawa M, Morishita Y, Shinohara A, Dewi N, Nonaka Y, Furuya Y, Mizumachi R, Murata Y, Nakamura H, Suzuki M, Sakurai Y, Tanaka H, Masunaga S, Ono K, Sugihara T, Nashimoto M, Yamauchi H, Ono M, Nakajima J, Takahashi H. Yanagie H, et al. Among authors: sugihara t. In Vivo. 2021 Nov-Dec;35(6):3125-3135. doi: 10.21873/invivo.12607. In Vivo. 2021. PMID: 34697143 Free PMC article.
Drug resistance of Pseudomonas aeruginosa based on the isolation sites and types of gastrointestinal diseases: An observational study.
Tsujimoto H, Fujikura Y, Hamamoto TA, Horiguchi H, Takahata R, Ishibashi Y, Sugihara T, Kouzu K, Itazaki Y, Fujishima SI, Okamoto K, Kajiwara Y, Matsukuma S, Ueno H. Tsujimoto H, et al. Among authors: sugihara t. Fukushima J Med Sci. 2024 Dec 18. doi: 10.5387/fms.24-00019. Online ahead of print. Fukushima J Med Sci. 2024. PMID: 39694500 Free article.
Selective peroxisome proliferator-activated receptor-α modulator improves hypertriglyceridemia and muscle quality in patients with chronic kidney disease: A retrospective observational study.
Mae Y, Takata T, Taniguchi S, Fujino Y, Kageyama K, Hanada H, Iyama T, Sugihara T, Isomoto H. Mae Y, et al. Among authors: sugihara t. Clin Nutr ESPEN. 2024 Nov 26;65:182-188. doi: 10.1016/j.clnesp.2024.11.029. Online ahead of print. Clin Nutr ESPEN. 2024. PMID: 39603346 Free article.
Pemafibrate for treating MASLD complicated by hypertriglyceridaemia: a multicentre, open-label, randomised controlled trial study protocol.
Iwaki M, Kobayashi T, Nogami A, Ogawa Y, Imajo K, Sakai E, Nakada Y, Koyama S, Kurihashi T, Oza N, Kohira T, Okada M, Yamaguchi Y, Iwane S, Kageyama F, Sasada Y, Matsushita M, Tadauchi A, Murohisa G, Nagasawa M, Sato S, Maeda K, Furuta K, Shigefuku R, Seko Y, Tobita H, Kawata K, Kawanaka M, Sugihara T, Tamaki N, Iwasa M, Kawaguchi T, Itoh Y, Kawaguchi A, Takahashi H, Nakajima A, Yoneda M. Iwaki M, et al. Among authors: sugihara t. BMJ Open. 2024 Nov 24;14(11):e088862. doi: 10.1136/bmjopen-2024-088862. BMJ Open. 2024. PMID: 39581726 Free PMC article. Clinical Trial.
829 results